Offer ends Jan 15.
|
|
New Year’s Offer: 40% OFF Health + Ancestry Service.
Limit 3. Offer ends Jan 15. Shop now |
|
Which gene could
empower you in 2024? |
See what our customers discovered and how
they took action. |
 |
|
| |
I called my mom. ‘I have this
gene! And I think you need to
get tested!’” |
| “I called my mom. ‘I have this gene! And I think you need to get tested!’” |
|
|
|
| Kenzie knew there was Ashkenazi Jewish heritage in her background but with no family history of breast cancer, she didn’t think there was a need to get screening for BRCA variants. But when Kenzie purchased 23andMe as a gift for herself and saw a ##### variant in her 23andMe report*, one of her first thoughts was whether her mom could have cancer and not know it. She immediately called her to encourage her to get tested. The two of them made appointments with their doctors for confirmatory
genetic testing and took steps to minimize their risks. |
|
|
|
You are receiving this email because you subscribed to 23andMe.
For information about our privacy practices, see our Privacy Statement.
Offer is valid for up to 3 of the same service type, placed in a single order on 23andme.com and shipped to a single address. Discount is automatically applied at checkout. Cannot be combined or used with any other discount, promotion or special pricing and cannot be applied to previous purchases. Offer ends on January 15, 2024.
*The 23andMe PGS test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to
make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Warnings & Limitations:
The 23andMe PGS Genetic Health Risk Report for #####/BRCA2 (Selected Variants) is indicated for reporting of 44 variants in the ##### and BRCA2 genes. The report describes if a person's genetic result is associated with an increased risk of developing breast cancer and ovarian cancer and may be associated with an increased risk for prostate cancer, pancreatic cancer, and potentially other cancers. The variants included in this report do not represent the majority of the #####/BRCA2 variants in people of most ethnicities. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of
other genetic variants that may impact cancer risk. This report is for over-the-counter use by adults over the age of 18, and provides genetic information to inform discussions with a healthcare professional. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed by an independent genetic test prescribed by your own healthcare provider before taking any medical action. For important information and limitations regarding each genetic health risk report, visit
23andme.com/test‑info/
© 2007 - 2024 23andMe, Inc.
23andMe, Inc. 349 Oyster Point Blvd, South San Francisco, CA 94080, USA
Unsubscribe from 23andMe news and updates emails |
|
|
|
|
|
|
